Celsis Analytical Services provides outsourced cGMP-certified laboratory services with sample turnaround times at its laboratory operations in Edison, New Jersey and St. Louis in the US.
The combined entity is believed to offer a comprehensive menu of methods validation and testing services for biotechnology, pharmaceutical and consumer products manufacturers, besides supplying and manufacturing raw materials.
AAIPharma CEO Patrick Walsh said Celsis Analytical would help AAIPharma expand its market presence in two key regions.
"Our combined company will bring a differentiated offering to the contract services market with an integrated development and material testing service model," Walsh added.
The terms of the deal have not been disclosed.